Published 3 days ago • loading... • Updated 3 days ago
Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence
Xellar Biosystems secured $50 million in Series A and A+ financing to develop its leading 3D Bio Intelligence platform.
The funding will expand Xellar's technology stack, including organ-on-chip systems, lab automation, imaging, multi-omics, and AI-driven biological modeling.
Xellar's platform centers on a closed-loop system combining human organ-on-chip models, automated experiments, and computational intelligence.
The new financing will boost Xellar's biological data automation, AI and computational biology teams, and virtual cell technology development.